BioXcel Therapeutics, Inc. 4 filing

Filed 2026-05-22 · Report date 2026-05-04 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001104659-26-065839
Form type: 4
CIK: 0001720893
Primary document: https://www.sec.gov/Archives/edgar/data/1720893/000110465926065839/xslF345X06/tm2615413-3_4seq1.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for BioXcel Therapeutics, Inc..

Reported financial metrics

Metric	Current	Prior	Change